Viewing StudyNCT05259722



Ignite Creation Date: 2024-05-06 @ 5:16 PM
Last Modification Date: 2024-10-26 @ 2:26 PM
Study NCT ID: NCT05259722
Status: COMPLETED
Last Update Posted: 2024-04-09
First Post: 2022-02-18

Brief Title: A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mgg Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema
Sponsor:
Organization: LEO Pharma

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 513
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: